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TO THE EDITOR
Warts (verrucae vulgares) are a com-
monly encountered dermatological dis-
order. Despite a vast body of research
on therapeutic modalities for warts, little
is known about the recent disease epi-
demiology. US population–based esti-
mates are lacking for the prevalence and
determinants of warts.
We used the 2007 National Health
Interview Survey, which was collected
by the National Center for Health
Statistics (NCHS) and is the principal
source of information on the health of
the civilian noninstitutionalized popula-
tion of the United States. Advance letters
with written informed consent were sent
to the home by the NCHS before the
survey. This study was approved by the
institutional review board at St Luke’s-
Roosevelt Hospital Center. The study
was conducted in adherence with the
guidelines of the Declaration of Hel-
sinki Principles. The questionnaire
included a core module about chil-
dren’s health with parental question-
naires to estimate the prevalence of
various child-health issues. The survey
was administered in-person to selected
households by the US Census Bureau
using approximately 400 trained inter-
viewers with computer-assisted personal
interviewing. One child was randomly
selected for the sample child question-
naire. Interviews were conducted in
English and Spanish. History of warts
was determined using the NHIS ques-
tion ‘‘During the past 12 months, has
(child) had warts?’’ Using data from the
US Census Bureau, sample weights
were adjusted for age, sex, race, ethni-
city, household size, and educational
attainment of the most educated house-
hold member to provide a data set that
was more representative of each state’s
population of noninstitutionalized chil-
dren o18 years of age. All prevalence
estimates presented reflect this complex
weighting.
All data processing and statistical
analyses were performed in SAS version
9.2. Univariate associations were tested
by Rao-Scott w2-tests. Complete data
analysis was performed. Correction for
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Figure 1. US prevalence of childhood warts varies by age. Data are presented as the percentage (95%
confidence interval) of subjects who responded yes to having warts in the past 12 months.
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multiple dependent tests (k¼ 7) with the
approach of Benjamini and Hochberg
(1995) yielded a critical P-value of
0.021.
Data were collected for 9,417 chil-
dren. Overall, the US prevalence (95%
CI) of warts in children was 3.3% (2.8–
3.8). The prevalence of warts steadily
increased between 1–2 and 7–8 years of
age, with a peak at 9–10 years and
reached plateau from 11 to 17 years
(Figure 1).
The prevalence of childhood warts
was highest in Caucasians, non-Hispa-
nics, and in households with greater
income, higher level of education, and
both parents present (Table 1). However,
there was no association between pre-
valence of warts and sex.
The present study provides US
population–based estimates of warts in
children, with peak prevalence occur-
ring at 9–10 years of age. A previous
study from a British birth cohort exam-
ined in the 1970s found 3.9 and 4.9%
prevalences of visible warts at ages
11 and 16 years, respectively (Williams
et al., 1993). A study of Egyptian
children found a 4.1% prevalence of
viral warts (Yamamah et al., 2012).
Similarly, we found an B4% pre-
valence of warts in these age groups.
Other studies of clinical cohorts
from dermatology and other medical
clinics found a broad range for the
diagnosis of warts in the United
States (2.4–16.2%) (Schachner et al.,
1983; Mallory et al., 1991; Yang et al.,
2007; Henderson et al., 2012). The
higher prevalences of warts found in
those prior studies were probably
because of referral and selection bias
related to the dermatology practice
setting.
We found significant racial/ethnic
and socioeconomic disparities, such
as that warts were more common in
Caucasians and non-Hispanics with
higher household income and level of
education. These results are consistent
with previous studies that found a higher
rate of warts in Caucasians than in
African Americans (Schachner et al.,
1983; Short et al., 1984; Mallory et al.,
1991; Alexis et al., 2007; Henderson
et al., 2012). A case series of 184
Arkansas children with warts found
that 157 (85.3%) were Caucasian and
only 27 (14.7%) were African American
(Mallory et al., 1991). Similarly, a
retrospective study of children with
warts found that 62.6% were
Caucasian and 37.4% were African
American, respectively (Schachner
Table 1. Determinants of childhood warts in the United States (n¼ 9,417)
No warts
(n¼9,168) Warts (n¼244)
Variable Freq Freq % Prev
95% Confidence
interval P-value1
Race
African American 1,681 11 0.81 (0.22–1.39) o0.0001
Caucasian 5,695 212 4.33 (3.65–5.01)
Asian 327 0 — (NE)
American Indian 131 2 0.84 (0.00–2.02)
Other/mixed 1,334 19 1.82 (0.79–2.86)
Hispanic/Spanish origin
No 6,335 208 3.87 (3.26–4.48) o0.0001
Yes 2,833 36 1.30 (0.78–1.82)
Sex
Male 4,740 122 3.07 (2.41–3.72) 0.27
Female 4,428 122 3.62 (2.87–4.37)
Household income ( $1,000)
0–49 4,399 83 2.56 (1.89–3.23) 0.002
50–99 2,710 86 3.83 (2.89–4.77)
X100 1,516 69 5.00 (3.62–6.38)
Other children in family
No (only child at home) 3,733 83 2.65 (2.05–3.25) 0.047
Yes 5,435 161 3.53 (2.92–4.14)
Highest level of education in household
Not a high-school graduate 1,239 8 0.92 (0.06–1.78) 0.0009
High-school graduate/GED 2,149 47 2.68 (1.69–3.67)
More than high-school
graduate
5,715 189 4.00 (3.34–4.65)
Family structure in home
Both parents 4,491 129 3.66 (2.94–4.38) 0.02
Single parent 4,253 111 3.23 (2.48–3.97)
No parents/other adults 421 4 0.75 (0.00–1.51)
Abbreviations: GED, passed the General Educational Development exam; NE, not estimable due to
zero-value.
Parental refusal to answer a particular question or response of ‘‘don’t know’’ occurred for the questions
pertaining to warts in 5 (0.1%), age in 0 (0.0%), race in 0 (0.0%), Hispanic/Spanish origin in 0 (0.05),
sex in 0 (0.0%), household income in 551 (5.3%), number of children in family in 0 (0.0%), highest
level of education in household in 65 (0.7%), and family structure in the home in 3 (0.04%).
Note: Groups with zero-values were excluded for the analyses of age and race.
1Rao-Scott w2-test.
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et al., 1983). A recent claims-based
study from Detroit, Michigan, found
that warts were more commonly
diagnosed in Caucasians (22.6%) than
in African Americans (5.7%) (Henderson
et al., 2012). A previous study of the
determinants of sexually transmitted
infections found that Caucasians were
more likely than African Americans to
have venereal warts (Short et al., 1984).
Furthermore, a recent prevalence study
of warts in Caucasian Dutch
schoolchildren aged 4–12 years showed
that one-third of the children had warts
(van Haalen et al., 2009). This suggests
that the incidence described in the
United States may actually be lower
than that in other countries owing to
the mixture of racial and ethnic groups
in our population.
The strengths of this study include
being a large-scale, US population–
based survey with minimal selection
bias, and controlling for confounding
demographic variables in multivariate
models. However, the study also has
some limitations. Warts and comorbid-
ities were assessed by caregiver report,
which have not been fully validated.
The appearance of common warts is
reasonably characteristic, and lay recog-
nition can be assumed to be good.
Another concern about self/parental-
reported warts is potential reporting
bias, where subjects with higher socio-
economic status may have better overall
health and be more motivated to seek
out care for warts. Future studies are
needed to validate the accuracy of self/
caregiver report and determine the ideal
survey instrument for the epidemiologic
study of these disorders.
The peak age of warts occurring at
9–10 years and common presence in
teenagers may relate to school atten-
dance and exposures from peer groups.
School- and family-based transmissions
have been cited as a leading cause of
disease (van Haalen et al., 2009). Age-
specific physical activity and sports
participation, particularly swimming
pool use (Penso-Assathiany et al.,
1999) and use of communal showers
(Johnson, 1995), have been linked to
transmission of warts. Racial/ethnic and
socioeconomic disparities may affect
age-specific activities and pool use.
Future studies are warranted to deter-
mine the role of age-specific physical
activities and local environment on the
US prevalence of warts.
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TO THE EDITOR
Rosacea is a chronic facial skin disease
with a presumed key vasodilatory
component (Steinhoff et al., 2011),
whereas diabetes mellitus (DM) is
associated with impaired vasodilation
congruent with the degree of
endothelial dysfunction. Insulin is a
physiologic regulator of the vascular
tone, but in the insulin-resistant state
insulin increases vasoconstriction
(Browne et al., 2003; Kim et al., 2006;
Rask-Madsen and King, 2007; Cade,
2008; Barrett et al., 2009; Ko et al.,
2010). Using the UK-based GeneralAccepted article preview online 8 May 2013; published online 27 June 2013
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DM, diabetes mellitus; GPRD, General Practice Research Database; HbA1c , hemoglobin A1c ; ISAC,
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Agency; NSAID, nonsteroidal anti-inflammatory drug; OAD, oral antidiabetic drug; OR, odds ratio
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